On this page:OverviewFunded papers
ScholarIQanswers from OpenAlex

Novo Nordisk Fonden

FunderResearch funding and supported work

Novo Nordisk Fonden is a funder indexed in ScholarIQ from OpenAlex.

How many works does Novo Nordisk Fonden have?

ScholarIQindexed works

Novo Nordisk Fonden has 45,663 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Novo Nordisk Fonden?

ScholarIQopenalex

The OpenAlex for Novo Nordisk Fonden is on the source record.

What is the ROR of Novo Nordisk Fonden?

ScholarIQror

The ROR for Novo Nordisk Fonden is on the source record.

What are the most-cited papers on Novo Nordisk Fonden?

ScholarIQmost cited works
Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials
Johannes F.E. Mann, Thomas K. Hansen, Thomas Idorn, Lawrence A. Leiter, Steven P. Marso, Peter Rossing, Jochen Seufert, Sayeh Tadayon, Tina Vilsbøll
The Lancet Diabetes & Endocrinology. 2020153 Citations
Severity of COVID-19 at elevated exposure to perfluorinated alkylates
Philippe Grandjean, Clara Amalie Gade Timmermann, Marie Kruse, Flemming Nielsen, Pernille Just Vinholt, Lasse Boding, Carsten Heilmann, Kåre Mølbak
PLoS ONE. 2020125 CitationsOPEN ACCESS
Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research
Trine Mechta Nielsen, Metha Frøjk Juhl, Bo Feldt‐Rasmussen, Thordis Thomsen
Clinical Kidney Journal. 2017114 CitationsOPEN ACCESS
Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical device
Evangelos K. Oikonomou, Alexios S. Antonopoulos, David Schottlander, M Marwan, Chris Mathers, Pete Tomlins, Muhammad Siddique, Laura Valentina Klüner, Cheerag Shirodaria, Michail C. Mavrogiannis, Sheena Thomas, Agostina M. Fava, John Deanfield, Keith M. Channon, Stefan Neubauer, Milind Y. Desai, Stephan Achenbach, Charalambos Antoniades
Cardiovascular Research. 2021100 CitationsOPEN ACCESS
The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: a nation-wide cohort study
Nikki C. C. Werkman, Johanna H. M. Driessen, Coen D.A. Stehouwer, Peter Vestergaard, Nicolaas C. Schaper, Joop P. van den Bergh, Johannes T. H. Nielen
Cardiovascular Diabetology. 202329 CitationsOPEN ACCESS
470M+ articles · 14-day free trial